These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29425507)

  • 21. Elevated expression of activins promotes muscle wasting and cachexia.
    Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
    FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth differentiation factor 11 (GDF11) has pronounced effects on skin biology.
    Idkowiak-Baldys J; Santhanam U; Buchanan SM; Pfaff KL; Rubin LL; Lyga J
    PLoS One; 2019; 14(6):e0218035. PubMed ID: 31181098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
    Fan X; Gaur U; Sun L; Yang D; Yang M
    Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments.
    Hatakeyama S; Summermatter S; Jourdain M; Melly S; Minetti GC; Lach-Trifilieff E
    Skelet Muscle; 2016; 6():26. PubMed ID: 27462398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.
    Nunn E; Jaiswal N; Gavin M; Uehara K; Stefkovich M; Drareni K; Calhoun R; Lee M; Holman CD; Baur JA; Seale P; Titchenell PM
    Mol Metab; 2024 Feb; 80():101880. PubMed ID: 38218536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of growth differentiation factor 11 on autophagy deficiency-induced dedifferentiation of arterial smooth muscle cells.
    Yuan X; Bhat OM; Lohner H; Li N; Zhang Y; Li PL
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H345-H356. PubMed ID: 30462553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic targeting of GDF11 in muscle atrophy: Insights and strategies.
    Wang C; Liu X; Hu X; Wu T; Duan R
    Int J Biol Macromol; 2024 Nov; 279(Pt 3):135321. PubMed ID: 39236952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.
    Fang Z; Zhu Z; Zhang H; Peng Y; Liu J; Lu H; Li J; Liang L; Xia S; Wang Q; Fu B; Wu K; Zhang L; Ginzburg Y; Liu J; Chen H
    Br J Haematol; 2020 Jan; 188(2):321-331. PubMed ID: 31418854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma.
    Zhang Y; Shao J; Wang Z; Yang T; Liu S; Liu Y; Fan X; Ye W
    Gene; 2015 Feb; 557(2):209-14. PubMed ID: 25534870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
    Schneyer AL; Sidis Y; Gulati A; Sun JL; Keutmann H; Krasney PA
    Endocrinology; 2008 Sep; 149(9):4589-95. PubMed ID: 18535106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
    Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
    Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GDF11 does not improve the palmitate induced insulin resistance in C2C12.
    Jing YY; Li D; Wu F; Gong LL; Li R
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1795-1802. PubMed ID: 28485800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDF11 improves tubular regeneration after acute kidney injury in elderly mice.
    Zhang Y; Li Q; Liu D; Huang Q; Cai G; Cui S; Sun X; Chen X
    Sci Rep; 2016 Oct; 6():34624. PubMed ID: 27703192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC; Walker RG; Murray NH; Thompson TB
    J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease.
    Pearsall RS; Davies MV; Cannell M; Li J; Widrick J; Mulivor AW; Wallner S; Troy ME; Spaits M; Liharska K; Sako D; Castonguay R; Keates S; Grinberg AV; Suragani RNVS; Kumar R
    Sci Rep; 2019 Aug; 9(1):11392. PubMed ID: 31388039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia.
    Pan C; Jaiswal Agrawal N; Zulia Y; Singh S; Sha K; Mohler JL; Eng KH; Chakkalakal JV; Krolewski JJ; Nastiuk KL
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32078585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDF11 does not rescue aging-related pathological hypertrophy.
    Smith SC; Zhang X; Zhang X; Gross P; Starosta T; Mohsin S; Franti M; Gupta P; Hayes D; Myzithras M; Kahn J; Tanner J; Weldon SM; Khalil A; Guo X; Sabri A; Chen X; MacDonnell S; Houser SR
    Circ Res; 2015 Nov; 117(11):926-32. PubMed ID: 26383970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar sequences but dissimilar biological functions of GDF11 and myostatin.
    Suh J; Lee YS
    Exp Mol Med; 2020 Oct; 52(10):1673-1693. PubMed ID: 33077875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.
    Pan C; Singh S; Sahasrabudhe DM; Chakkalakal JV; Krolewski JJ; Nastiuk KL
    Endocrinology; 2016 Nov; 157(11):4461-4472. PubMed ID: 27611336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GDF11 administration does not extend lifespan in a mouse model of premature aging.
    Freitas-Rodríguez S; Rodríguez F; Folgueras AR
    Oncotarget; 2016 Aug; 7(35):55951-55956. PubMed ID: 27507054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.